The Rationale for GesEPOC in Our Environment

Arch Bronconeumol. 2017 Jun;53(6):293-294. doi: 10.1016/j.arbres.2017.04.004. Epub 2017 May 8.
[Article in English, Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Bronchodilator Agents / therapeutic use*
  • Disease Progression
  • Humans
  • Phenotype
  • Practice Guidelines as Topic*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Quality of Life
  • Risk Assessment
  • Severity of Illness Index
  • Spain

Substances

  • Bronchodilator Agents